As men age, they often encounter various changes in the reproductive system. One of the most common clinical presentations is Benign Prostatic Hypertrophy (BPH). While the name might sound intimidating, it is important to distinguish this condition from prostate cancer. BPH is a non-malignant condition characterized by the enlargement of the prostate gland, which can lead to significant urinary complications if left untreated.
What is Benign Prostatic Hypertrophy?
Benign Prostatic Hypertrophy (BPH) is a condition common in older men that varies in severity from mild to severe. Despite the term "hypertrophy" (which often refers to an increase in cell size), the actual physiological change occurring in the prostate is hyperplasia.
Hyperplasia refers to an increase in the number of cells within an organ or tissue. In the case of BPH, these new cells form nodules within the inner part of the prostate gland. It is crucial for clinicians to note that BPH has no connection to prostate cancer. While BPH arises from the center of the gland, prostate cancer typically originates from tissue near the surface (the periphery) of the gland.
Pathophysiology: From Compression to Obstruction
The primary clinical issue with BPH is the location of the hyperplastic nodules. Because these nodules form in the inner prostate, they physically press against the urethra—the tube responsible for carrying urine out of the body.
Keep reading for free.
Create an account to finish this reading and make it part of your study routine.
Continue reading freeAlready have an account? Log in
Updated